Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer

The Latest News from BioAgilytix

December 4, 2017

BioAgilytix Welcomes Mark Bethers as Global Vice President of Human Resources

Mr. Bethers Brings More Than 20 Years of Experience as a Human Resources Professional in the Global Biopharma Manufacturing and Professional Services Space DECEMBER 4, 2017—Durham, NC—BioAgilytix, a leading provider…

Read More

November 14, 2017

BioAgilytix Recognized with a Top 4 Ranking in the Triangle Business Journal’s 2017 Fast 50 Awards

The Bioanalytical Laboratory Has Been Named One of the Triangle’s Fastest Growing Companies for the Fifth Time in Seven Years NOVEMBER 14, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical…

Read More

September 7, 2017

BioAgilytix Completes Bioanalytical Laboratory Expansion at Its USA Headquarters

The Addition of Nearly 21,000 Square Feet Increases Capacity to Support Even the Largest Studies and Sample Analysis Needs September 7, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing…

Read More

BioAgilytix award - Inc. 5000
August 16, 2017

BioAgilytix Named to Inc. Magazine’s 2017 Inc. 5000 List of Fastest-Growing Private U.S. Companies

The Bioanalytical Laboratory Earns Spot in Exclusive Ranking for the Fourth Time in Five Years August 16, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in…

Read More

August 7, 2017

BioAgilytix Receives Triangle Business Journal’s Leaders in Diversity Award for 2017

Award Recognizes the Bioanalytical Laboratory’s Commitment to Diversity in the Workplace August 7, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has…

Read More

June 19, 2017

BioAgilytix Welcomes Samuel Pine to Leadership Team as Director of Bioanalytical Operations, Europe

Dr. Pine Brings Over 23 Years of Experience Supporting Biotherapeutic, Vaccine, and Immunodiagnostic Drug Development from Discovery Through Post-Marketing June 19, 2017—Durham, NC and Hamburg, Germany—BioAgilytix, a leading provider of…

Read More

June 12, 2017

BioAgilytix CFO Todd Lynch Named to 2017 Class of CFO of the Year Award Winners by Triangle Business Journal

Lynch Recognized for Strategic Leadership During BioAgilytix’s Exceptional Growth June 12, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced that…

Read More

May 18, 2017

BioAgilytix Implements BD FACSLyric™ Platform in Its European Laboratory

High-Performance Clinical Cell Analyzer Enhances BioAgilytix’s Flow Cytometry Capabilities and Extends Capacity for Immune Response Monitoring and Cell Line Characterization MAY 18, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical…

Read More

May 18, 2017

BioAgilytix Further Expands Its European Laboratory Capacity for Immunogenicity Studies with an Additional Biacore™ T200 Platform

Innovative Instrument Supports BioAgilytix’s Characterization of Biomolecular Interactions and Monitoring and Characterization of ADAs from Preclinical to Clinical Development MAY 22, 2017—Durham, NC—BioAgilytix, a leading global provider of contract bioanalytical…

Read More

May 8, 2017

BioAgilytix Grows Its Portfolio of Meso Scale Discovery Electrochemiluminescence (MSD-ECL) Platforms to Over 10 Operating in its USA and European Labs

BioAgilytix Remains the Premier Bioanalytical CRO Providing PK, ADA, NAb and Biomarker Analysis Utilizing MSD-ECL to Support Global Large Molecule Studies MAY 8, 2017—Durham, NC—BioAgilytix, a leading provider of contract…

Read More

April 12, 2017

BioAgilytix Officially Opens New, Expanded Laboratory in Hamburg, Germany for Its Subsidiary IPM Biotech

The New 1,765 Square Meter Facility Greatly Extends the Footprint of IPM Biotech’s Former Hamburg Lab Location and will Act as BioAgilytix’s European Headquarters April 12, 2017—Durham, NC and Hamburg,…

Read More

March 9, 2017

Triangle Business Journal: Durham’s BioAgilytix heading into expansion mode

BioAgilytix is beefing up in Durham. The contact research organization is expanding its existing 29,000-square-foot space to roughly 50,000 square feet at 2300 Englert Drive and is planning to hire…

Read More

February 28, 2017

BioAgilytix and ATCC Partnership Proves Effective for Sponsors Seeking Comprehensive Cell-Based Assay Development Services and Expertise

Customers Have Access to a Joint Team with Expertise Ranging from Research to Good Manufacturing Practice (GMP) FEBRUARY 28, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with…

Read More

January 30, 2017

BioAgilytix Welcomes Jeff Sailstad as USA Chief Scientific Officer

Mr. Sailstad Brings Over 35 Years of Experience Developing, Validating, and Applying Regulatory-Compliant Methods for Biological and Immunological-Based Testing JANUARY 30, 2017–Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing…

Read More